Literature DB >> 7629148

Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface.

X Chen1, G Raab, U Deutsch, J Zhang, R M Ezzell, M Klagsbrun.   

Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) gene expression and protein localization were analyzed during the process of myogenic differentiation. The mouse HB-EGF gene was isolated, and a 1.8-kilobase genomic fragment flanking the 5' end of the cDNA was cloned. This fragment contains two sequences which match the consensus CANNTG sequence for E-boxes, binding sites for the MyoD family of DNA-binding transcription factors that regulate myogenesis. Accordingly, HB-EGF synthesis was analyzed in 10T1/2 cells and C2C12 cells which are used commonly for the study of myogenesis. HB-EGF gene expression was upregulated in both cell types during myogenesis. In 10T1/2 cells, direct activation of HB-EGF gene expression by MyoD was shown in that: i) transient transfection of these cells with a plasmid expressing MyoD resulted in a 10-20-fold increase in endogenous HB-EGF mRNA levels; ii) co-transfection of MyoD and an HB-EGF promoter-reporter plasmid resulted in a 5-10-fold increase in reporter activity, an increase that was abrogated by deletion of a putative HB-EGF proximal E-box sequence; and iii) incubation of MyoD protein with a 25-base pair double-stranded oligonucleotide corresponding to the HB-EGF proximal E-box sequence resulted in retarded electrophoretic mobility of the oligonucleotide. In C2C12 cells, differentiation of myoblasts into myotubes resulted in a 40-50-fold increase in HB-EGF promoter activity. In addition, immunostaining and laser confocal microscopy detected HB-EGF protein in C2C12 myotubes but not in myoblasts. The HB-EGF produced was in its transmembrane form and localized to the myotube surface. Taken together, it was concluded that during skeletal muscle cell differentiation, MyoD plays a direct role in activating HB-EGF gene expression and that HB-EGF protein is expressed preferentially in myotubes and in its membrane-anchored form.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629148     DOI: 10.1074/jbc.270.31.18285

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.

Authors:  S l Fu; I Bottoli; M Goller; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling.

Authors:  Eva Brauers; Agnes Dreier; Andreas Roos; Berthold Wormland; Joachim Weis; Alexander Krüttgen
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

3.  Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder.

Authors:  M R Freeman; J J Yoo; G Raab; S Soker; R M Adam; F X Schneck; A A Renshaw; M Klagsbrun; A Atala
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.

Authors:  G J Jenniskens; A Oosterhof; R Brandwijk; J H Veerkamp; T H van Kuppevelt
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

5.  Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors.

Authors:  J H Xiao; X Feng; W Di; Z H Peng; L A Li; P Chambon; J J Voorhees
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

6.  Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.

Authors:  S A McCarthy; D Chen; B S Yang; J J Garcia Ramirez; H Cherwinski; X R Chen; M Klagsbrun; C A Hauser; M C Ostrowski; M McMahon
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

7.  Identification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1.

Authors:  Annelize Z B Aragão; Maria Luiza C Nogueira; Daniela C Granato; Fernando M Simabuco; Rodrigo V Honorato; Zaira Hoffman; Sami Yokoo; Francisco R M Laurindo; Fabio M Squina; Ana Carolina M Zeri; Paulo S L Oliveira; Nicholas E Sherman; Adriana F Paes Leme
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

8.  Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.

Authors:  Kohei Miyata; Fusanori Yotsumoto; Sung Ouk Nam; Takashi Odawara; Sadao Manabe; Toyokazu Ishikawa; Hiroaki Itamochi; Junzo Kigawa; Shuji Takada; Hiroshi Asahara; Masahide Kuroki; Shingo Miyamoto
Journal:  Cancer Med       Date:  2014-07-24       Impact factor: 4.452

Review 9.  Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis.

Authors:  Fabrizio Vinante; Antonella Rigo
Journal:  Toxins (Basel)       Date:  2013-06       Impact factor: 4.546

10.  Deep RNA sequencing of the skeletal muscle transcriptome in swimming fish.

Authors:  Arjan P Palstra; Sergi Beltran; Erik Burgerhout; Sebastiaan A Brittijn; Leonardo J Magnoni; Christiaan V Henkel; Hans J Jansen; Guido E E J M van den Thillart; Herman P Spaink; Josep V Planas
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.